We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$228M
AUM Growth
+$28.2M
Cap. Flow
+$16.3M
Cap. Flow %
7.18%
Top 10 Hldgs %
22.49%
Holding
2,261
New
155
Increased
919
Reduced
268
Closed
73

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$3.24M
2
VIVO
Meridian Bioscience Inc
VIVO
+$2.22M
3
VGT icon
Vanguard Information Technology ETF
VGT
+$1.31M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$1.05M
5
MLPI
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
+$1.04M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$12.5M
2
HD icon
Home Depot
HD
+$5.18M
3
IWB icon
iShares Russell 1000 ETF
IWB
+$555K
4
ESRX
Express Scripts Holding Company
ESRX
+$401K
5
IWM icon
iShares Russell 2000 ETF
IWM
+$401K

Sector Composition

Rank Sector Weight
1 Financials 10.77%
2 Healthcare 8.96%
3 Consumer Staples 8.9%
4 Technology 8.86%
5 Industrials 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAE icon
1526
Haemonetics
HAE
$3.58B
$1K ﹤0.01%
38
– –
HAIN icon
1527
Hain Celestial
HAIN
$47.8M
$1K ﹤0.01%
41
– –
HLX icon
1528
Helix Energy Solutions
HLX
$1.46B
$1K ﹤0.01%
189
-19
-9% -$153
HUBG icon
1529
HUB Group
HUBG
$3.01B
$1K ﹤0.01%
76
– –
HUBS icon
1530
HubSpot
HUBS
$10.5B
$1K ﹤0.01%
+27
New +$1.53K
HUN icon
1531
Huntsman Corp
HUN
$2.24B
$1K ﹤0.01%
65
+3
+5% +$65
IART icon
1532
Integra LifeSciences
IART
$1.54B
$1K ﹤0.01%
38
– –
ICL icon
1533
ICL Group
ICL
$6.81B
$1K ﹤0.01%
250
-25
-9% -$111
IDA icon
1534
Idacorp
IDA
$8.23B
$1K ﹤0.01%
16
– –
ICUI icon
1535
ICU Medical
ICUI
$3.93B
$1K ﹤0.01%
9
– –
IDCC icon
1536
InterDigital
IDCC
$6.68B
$1K ﹤0.01%
28
– –
IOSP icon
1537
Innospec
IOSP
$2.09B
$1K ﹤0.01%
23
– –
IPAR icon
1538
Interparfums
IPAR
$3.92B
$1K ﹤0.01%
32
– –
IPGP icon
1539
IPG Photonics
IPGP
$3.89B
$1K ﹤0.01%
11
– –
IRBT
1540
DELISTED
iRobot
IRBT
$1K ﹤0.01%
26
– –
OPLN
1541
Openlane
OPLN
$4.17B
$1K ﹤0.01%
106
– –
KBR icon
1542
KBR
KBR
$4.68B
$1K ﹤0.01%
88
-672
-88% -$10.7K
KELYA icon
1543
Kelly Services Class A
KELYA
$526M
$1K ﹤0.01%
70
– –
KGC icon
1544
Kinross Gold
KGC
$28.5B
$1K ﹤0.01%
323
-22
-6% -$79
KLIC icon
1545
Kulicke & Soffa
KLIC
$5.3B
$1K ﹤0.01%
96
– –
LBRDK icon
1546
Liberty Broadband Class C
LBRDK
$4.15B
$1K ﹤0.01%
12
-21
-64% -$1.75K
LCII icon
1547
LCI Industries
LCII
$2.51B
$1K ﹤0.01%
17
– –
LEG icon
1548
Leggett & Platt
LEG
$1.52B
$1K ﹤0.01%
37
+8
+28% +$391
LGND icon
1549
Ligand Pharmaceuticals
LGND
$6.02B
$1K ﹤0.01%
26
– –
LPSN icon
1550
LivePerson
LPSN
$18.9M
$1K ﹤0.01%
12
– –
60 61
62
63 64

Similar funds

BDLIB
Banque de Luxembourg Investments (BLI) Luxembourg City, Luxembourg $3.34B AUM 11.13% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
HP
Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM

Quadrant Capital Group's Q1 2017 Portfolio in Review

As of Q1 2017, Quadrant Capital Group held 2,261 positions worth $228M, up 14% from $199M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Quadrant Capital Group deployed $16.3M of net new capital in Q1 2017, opening 155 new positions and adding to 919 existing holdings. Its largest new stake was Meridian Bioscience Inc: 158,483 shares worth $2.19M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Procter & Gamble, an estimated $12.5M trimmed.

  • Quadrant Capital Group's largest Q1 2017 buy was Meridian Bioscience Inc: 158,483 shares worth $2.19M.
  • Quadrant Capital Group added most to Vanguard Total Stock Market ETF in Q1 2017, an estimated $3.24M increase.
  • Quadrant Capital Group's biggest Q1 2017 reduction was Procter & Gamble, cutting an estimated $12.5M.
  • Quadrant Capital Group fully exited Harman International Industries in Q1 2017, selling an estimated $104K.
  • Quadrant Capital Group's ten largest holdings make up 22% of its $228M portfolio in Q1 2017.
  • Quadrant Capital Group opened 155 new positions and closed 73 in Q1 2017.
  • Quadrant Capital Group's portfolio value rose 14% quarter-over-quarter to $228M.

Based on Quadrant Capital Group's 13F filing for Q1 2017, filed 10 Apr 2017.